{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T19:26:43Z","timestamp":1757705203518},"reference-count":0,"publisher":"MJH Life Sciences","issue":"3601","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.46883\/2022.25920940","type":"journal-article","created":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T17:56:18Z","timestamp":1643133378000},"source":"Crossref","is-referenced-by-count":9,"title":["Current Frontline Treatment of Diffuse Large B-Cell Lymphoma"],"prefix":"10.46883","member":"25947","published-online":{"date-parts":[[2022,1]]},"container-title":["ONCOLOGY"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T17:56:19Z","timestamp":1643133379000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cancernetwork.com\/view\/journal-current-frontline-treatment-of-diffuse-large-b-cell-lymphoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":0,"issue-title":["January 2022"],"journal-issue":{"issue":"3601","published-online":{"date-parts":[[2022]]},"published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.46883\/2022.25920940","relation":{},"ISSN":["0890-9091"],"issn-type":[{"type":"print","value":"0890-9091"}],"subject":[],"published":{"date-parts":[[2022,1]]}}}